IMMIGRATION

Revised Travel Ban Issued

We recently outlined the major effects and the steps you can take to manage the impact of the travel ban executive order (See G2 Compliance Advisor, February 2017). Although that guidance was based on … [Read more...]

INVESTMENTS

Inside the Lab Industry: Silicon Valley Bank Reports Steady 2016 Dx Investments, Declining Exits

Investments in the diagnostics and tools (Dx/Tools) sector remained steady in 2016, according to Silicon Valley Bank's annual report, Trends in Healthcare Investments and Exits 2017. The report's … [Read more...]

NEWS

The 6 Things Labs Need to Know About the Trump Travel Ban

Although the first Trump travel ban didn't survive, a new version is already in the works. Although we don't yet know the details, the expectation is that the new travel ban will look a whole lot like … [Read more...]

NEWS

Industry Newsmaker: Veracyte, Inc. Scores Big with Percepta and Affirma GEC

Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew significantly. Percepta Gets Thumbs Up … [Read more...]

INDUSTRY BUZZ

Deal of the Month: $25 Billion Acquisition of St. Jude Med Cements Abbott as Leader in Cardiovascular Device Market

In a month with an unusually heavy volume of diagnostic deal making, the headline story was Abbott Laboratories' $25 billion purchase of fellow device-making giant St. Jude Medical, which finally … [Read more...]

INDUSTRY BUZZ

Arizona Fraud Suit Opens New Front in the Legal War against Theranos

The Arizona Attorney General's Office (AGO) recently issued a request for proposal signaling a new legal battle for Theranos: state consumer fraud lawsuits. The AGO indicated in its request that it … [Read more...]

REIMBURSEMENT

Update on Palmetto’s Molecular Dx Testing LCDs

Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for payors as far as coverage is concerned. Normally … [Read more...]

LEGISLATION

New Laws: Civil Monetary Penalties Get More Expensive—and Easier to Dish Out

One aspect of the Affordable Care Act (ACA) that is not likely to be repealed is the enhancement of penalties for Medicare and Medicaid fraud and abuse. That includes the new Regulation on civil … [Read more...]

LCDs

Palmetto Latest Medicare Contractor to Loosen Up on Covering Molecular Dx Testing

Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for payors as far as coverage is concerned. Normally … [Read more...]

FEE SCHEDULES

3 Things You Need to Know about the Lab Fee Schedule

The Centers for Medicare and Medicaid Services (CMS) issued the final 2017 Clinical Laboratory Fee Schedule (CLFS) on Nov. 21. Here is a look at the three key changes you need to know about going into … [Read more...]


(-0000g2)